Linked Data API

Show Search Form

Search Results

1037967
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading CJD more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve diagnosis rates of sporadic Creutzfeldt-Jakob disease. more like this
star this property tabling member constituency Witham more like this
star this property tabling member printed
Priti Patel more like this
star this property uin 206318 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-01-16more like thismore than 2019-01-16
star this property answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property grouped question UIN
206320 more like this
206323 more like this
206326 more like this
206327 more like this
star this property question first answered
less than 2019-01-16T15:05:48.437Zmore like thismore than 2019-01-16T15:05:48.437Z
unstar this property answering member
4067
star this property label Biography information for Steve Brine more like this
unstar this property tabling member
4066
unstar this property label Biography information for Priti Patel more like this
1037969
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading CJD more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the symptoms of sporadic Creutzfeldt-Jakob disease are identified at the earliest opportunity. more like this
star this property tabling member constituency Witham more like this
star this property tabling member printed
Priti Patel more like this
star this property uin 206320 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-01-16more like thismore than 2019-01-16
star this property answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property grouped question UIN
206318 more like this
206323 more like this
206326 more like this
206327 more like this
star this property question first answered
less than 2019-01-16T15:05:48.497Zmore like thismore than 2019-01-16T15:05:48.497Z
unstar this property answering member
4067
star this property label Biography information for Steve Brine more like this
unstar this property tabling member
4066
unstar this property label Biography information for Priti Patel more like this
1037974
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading CJD more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many people were diagnosed with sporadic Creutzfeldt-Jakob Disease in (a) Witham constituency, (b) the East of England and (c) England and Wales in the most recent five years for which data is available. more like this
star this property tabling member constituency Witham more like this
star this property tabling member printed
Priti Patel more like this
star this property uin 206323 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-01-16more like thismore than 2019-01-16
star this property answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property grouped question UIN
206318 more like this
206320 more like this
206326 more like this
206327 more like this
star this property question first answered
less than 2019-01-16T15:05:48.56Zmore like thismore than 2019-01-16T15:05:48.56Z
unstar this property answering member
4067
star this property label Biography information for Steve Brine more like this
unstar this property tabling member
4066
unstar this property label Biography information for Priti Patel more like this
1037977
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading CJD more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department has taken to raise awareness among medical professionals of the symptoms of (a) sporadic, (b) variant, (c) genetic and (d) Iatrogenic Creutzfeldt-Jakob Disease. more like this
star this property tabling member constituency Witham more like this
star this property tabling member printed
Priti Patel more like this
star this property uin 206326 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-01-16more like thismore than 2019-01-16
star this property answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property grouped question UIN
206318 more like this
206320 more like this
206323 more like this
206327 more like this
star this property question first answered
less than 2019-01-16T15:05:48.607Zmore like thismore than 2019-01-16T15:05:48.607Z
unstar this property answering member
4067
star this property label Biography information for Steve Brine more like this
unstar this property tabling member
4066
unstar this property label Biography information for Priti Patel more like this
1037985
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading CJD more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what the average waiting time has been for a diagnosis of sporadic Creutzfeldt-Jakob Disease (CJD) in the last five years for which data is available. more like this
star this property tabling member constituency Witham more like this
star this property tabling member printed
Priti Patel more like this
star this property uin 206327 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-01-16more like thismore than 2019-01-16
star this property answer text <p>Early diagnosis of sporadic Creutzfeldt-Jakob Disease (sCJD) is challenging as the disorder is rare, and symptoms are non-specific, mimicking those seen in more common neurodegenerative, neuroinflammatory, and infectious disorders. Rapidity of progression and lack of response to treatment often leads clinicians to suspect a CJD diagnosis.</p><p> </p><p>The Department and the Scottish Government fund the National CJD Research and Surveillance Unit (NCJDRSU) to provide inter-disciplinary clinical and laboratory expertise (neurology, neuroradiology, neuropathology, biochemistry, and epidemiology) enabling early and accurate diagnosis of CJD. Clinicians from across the United Kingdom can discuss cases at any time. Highly trained specialists assess suspected cases locally within five days of referral and conduct structured assessments (clinical history, examination, and review of investigation results) before establishing diagnoses based on validated criteria. A consultant neuroradiologist at the NCJDRSU assesses neuroimaging for patients throughout the UK with a suspicion of CJD. The unit also provides a national diagnostic cerebrospinal fluid (CSF) 14-3-3/RT-QuIC service and will arrange collection of CSF samples with prompt results. Information on how clinicians can refer cases to the NCJDRSU is available at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/referral-system" target="_blank">http://www.cjd.ed.ac.uk/surveillance/referral-system</a></p><p> </p><p>The Department and the Scottish Government have funded the development of diagnostic tests that combined with improved interpretation of neuroimaging has improved diagnostic accuracy.</p><p> </p><p>The NCJDRSU collects data on the number of people diagnosed with sCJD in the UK; break downs by of data for smaller geographies are not published. The following table shows a breakdown of the number of individuals, by year of death between 2014 and 2017. Date of diagnosis are considered synonymous for the purpose of reporting.</p><p> </p><p>Number of sCJD 2014-18 in the UK by year of death (as at January 2019).</p><table><tbody><tr><td><p>Year of death</p></td><td><p>Number</p></td></tr><tr><td><p>2014</p></td><td><p>99</p></td></tr><tr><td><p>2015</p></td><td><p>105</p></td></tr><tr><td><p>2016</p></td><td><p>119</p></td></tr><tr><td><p>2017</p></td><td><p>120</p></td></tr><tr><td><p>2018</p></td><td><p>125</p></td></tr></tbody></table><p>Source: NCJDRSU: <a href="https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf" target="_blank">https://www.cjd.ed.ac.uk/sites/default/files/figs.pdf </a></p><p> </p><p>The NCJDRSU presents data regularly at clinical meetings and publishes in peer reviewed medical journals accessed by medical professionals, as well as producing a detailed annual report at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf" target="_blank">http://www.cjd.ed.ac.uk/sites/default/files/report26.pdf</a></p><p> </p><p>The NCJDRSU website also provides information on the different types of CJD at the following link:</p><p> </p><p><a href="http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing" target="_blank">http://www.cjd.ed.ac.uk/surveillance/diagnosis-and-testing</a></p><p> </p><p>sCJD is a rapidly progressive neurological disorder with an average time from first symptom onset to death of four months. The majority (88%) of individuals with sCJD over the past five years were assessed by clinicians from the NCJDRSU in life. After formal referral to NCJDRSU the average time to confirmation of the diagnosis was three days.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property grouped question UIN
206318 more like this
206320 more like this
206323 more like this
206326 more like this
star this property question first answered
less than 2019-01-16T15:05:48.67Zmore like thismore than 2019-01-16T15:05:48.67Z
unstar this property answering member
4067
star this property label Biography information for Steve Brine more like this
unstar this property tabling member
4066
unstar this property label Biography information for Priti Patel more like this
1037808
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Skin Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that strategies to (a) tackle and (b) prevent skin cancers are based on the most up to date research. more like this
star this property tabling member constituency Weaver Vale more like this
star this property tabling member printed
Mike Amesbury more like this
star this property uin 206461 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-01-11more like thismore than 2019-01-11
star this property answer text <p>The NHS Long Term Plan sets out how the National Health Service plans to improve outcomes against all cancers. The Long Term Plan was developed together with stakeholders across the health and care sector, and is based on the latest evidence.</p><p> </p><p>Public Health England (PHE) is carrying out research to investigate the contribution of ultraviolet light (UV) to skin cancer in a comprehensive way, which aims to minimise the detrimental effects of UV while maximising the potential benefits of UV in vitamin D production and potentially in mitigating high blood pressure. Through public events, PHE informs the public of the risk and potential benefits of sunshine and practical measures to take to prevent skin cancer.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-01-11T13:08:48.227Zmore like thismore than 2019-01-11T13:08:48.227Z
unstar this property answering member
4067
star this property label Biography information for Steve Brine more like this
unstar this property tabling member
4667
unstar this property label Biography information for Mike Amesbury more like this
1037873
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Abortion more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what estimate he has made of the costs to the NHS per treatment of (a) a medical abortion and (b) a surgical abortion via (i) an NHS provider and (ii) a private provider. more like this
star this property tabling member constituency Walthamstow more like this
star this property tabling member printed
Stella Creasy more like this
star this property uin 206348 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-01-11more like thismore than 2019-01-11
star this property answer text <p>This data is not available in the format requested. Data on reference costs is collected from National Health Service providers but the relevant return includes costs relating to stillbirths and miscarriages. No such data is collected from non-NHS providers.</p> more like this
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property question first answered
less than 2019-01-11T15:16:27.037Zmore like thismore than 2019-01-11T15:16:27.037Z
unstar this property answering member
4065
star this property label Biography information for Dame Jackie Doyle-Price more like this
unstar this property tabling member
4088
unstar this property label Biography information for Stella Creasy more like this
1037922
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Dentistry: Fines more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 September 2018 to Question 167266, how many FP17 forms have not been accepted by the NHS Business Services Authority due to concerns about the address provided for the patient. more like this
star this property tabling member constituency Walthamstow more like this
star this property tabling member printed
Stella Creasy more like this
star this property uin 206351 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-01-11more like thismore than 2019-01-11
star this property answer text <p>This information is not held.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-01-11T13:09:18.883Zmore like thismore than 2019-01-11T13:09:18.883Z
unstar this property answering member
4067
star this property label Biography information for Steve Brine more like this
unstar this property tabling member
4088
unstar this property label Biography information for Stella Creasy more like this
1037778
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Air Pollution more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 October 2018 to Question 174612 on Air Pollution, what plans his Department has to further study the effects of PM0.1 and PM1 particles on human health. more like this
star this property tabling member constituency Stroud more like this
star this property tabling member printed
Dr David Drew more like this
star this property uin 206215 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-01-16more like thismore than 2019-01-16
star this property answer text <p>Recent assessments have been undertaken of the health effects of long-term exposure to the air pollution mixture in the United Kingdom, but no separate assessments of the impact of the PM1 and PM0.1 components (particulate matter with an aerodynamic diameter smaller than 1 or 0.1 microns, respectively) of particulate air pollution have been produced.</p><p> </p><p>The reviews by the Health Effects Institute and the World Health Organization about the effects of different components of air pollution, including ultrafine particles (PM0.1), concluded that there is currently limited evidence on the effects on health of ultrafine particles. These reviews are available at the following link:</p><p> </p><p><a href="https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles" target="_blank">https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles</a></p><p> </p><p><a href="http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1" target="_blank">http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1</a></p><p> </p><p>Currently, Public Health England has no plans to engage in work on the effects of PM1 and PM0.1 particles on human health over the coming year.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-01-16T12:30:56.92Zmore like thismore than 2019-01-16T12:30:56.92Z
unstar this property answering member
4067
star this property label Biography information for Steve Brine more like this
unstar this property tabling member
252
unstar this property label Biography information for Dr David Drew more like this
1037779
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care remove filter
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Public Health: Fuel Poverty more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the effects of fuel poverty on public health. more like this
star this property tabling member constituency Stroud more like this
star this property tabling member printed
Dr David Drew more like this
star this property uin 206216 more like this
star this property answer
answer
star this property is ministerial correction false more like this
unstar this property date of answer less than 2019-01-16more like thismore than 2019-01-16
star this property answer text <p>The causes of excess winter death and illness are complex and interlinked, and include circulating diseases such as influenza, cold temperatures and wider determinants of health, such as poor housing and fuel poverty. It is difficult to attribute the relative impacts of each of these factors as the contribution varies year on year.</p><p> </p><p>Living in a cold home and being in fuel poverty represent a significant risk to health, wellbeing and inequalities. The joint Public Health England and University College London Institute of Health Equity report ‘Local action on health inequalities: Fuel poverty and cold home-related health problems’ reported that an estimated 21.5% of annual excess winter deaths are attributable to the coldest quarter of housing. The report is available to view at the following link:</p><p> </p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/355790/Briefing7_Fuel_poverty_health_inequalities.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/355790/Briefing7_Fuel_poverty_health_inequalities.pdf</a></p><p> </p><p>The Public Health Outcomes Framework (PHOF) includes an Excess Winter Deaths Index and a Fuel Poverty indicator, available to view at the following link:</p><p> </p><p><a href="https://fingertips.phe.org.uk/search/fuel%20poverty#page/3/gid/1/pat/6/par/E12000007/ati/102/are/E09000022/iid/90356/age/1/sex/4" target="_blank">https://fingertips.phe.org.uk/search/fuel%20poverty#page/3/gid/1/pat/6/par/E12000007/ati/102/are/E09000022/iid/90356/age/1/sex/4</a></p><p> </p><p>Local government use PHOF to assess the scale of the problem locally and are supported to take action through both the Cold Weather Plan for England and the National Institute for Health and Care Excellence Guidelines.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2019-01-16T12:28:53.357Zmore like thismore than 2019-01-16T12:28:53.357Z
unstar this property answering member
4067
star this property label Biography information for Steve Brine more like this
unstar this property tabling member
252
unstar this property label Biography information for Dr David Drew more like this